EFTA01964139

To: Jeffrey Epsteinueevacation©gmail.com] From: Boris Woke Sent Wed 7/24/2013 8:20:59 PM Subject FW: Draft Email Still waiting for the other document Sent from my Windows Phone From: Larry Cohen Sent: 7/24/2013 9:40 PM To: Boris Nikolic Subject: Draft Email Hi Boris — here is a rough draft of email/messaging. Send any comments/edits my way and we can keep working on this. It is both exciting and sad news that today we are announcing Boris will be transitioning from his roles at bgC3 and the Foundation to embark on the next phase of his career. I first met Boris 6 years ago when he was managing an immunology laboratory he founded at Massachusetts General/Harvard Medical School. i recruited him to come to our Foundation where he spent 3 years working on diagnostics and other critical global health initiatives. For the past 3 years Boris has worked closely with me on both foundation-related work and on new science innovation opportunities. Boris has demonstrated a strong ability and passion for identifying and nurturing promising, early- stage companies doing breakthrough work in science and technology. With this in mind we've always planned on an eventual transition where Boris can focus 100% of his time on this type work and begin to pursue those opportunities outside of our structure. Now, with our programs established and working so well the time has come for Boris to fulfill this ambition. Although i am sad to see him go, he does so with my full support and confidence. We are committed to managing a smooth transition and not missing a beat on critical projects. Boris will continue working with us in a managed transition through the end of this year. Boris EFTA_R1_00440723 EFTA01964139 will be relocating to New York (an epicenter for the future work he will do) and will work directly with the relevant Foundation and external teams and project leads on transition plans. We are extremely thankful for the impact Boris has had on our work and success. Boris, thank you and best of luck in your future endeavors. E FTA_R 1_00440724 EFTA01964140